In Uzbekistan, media reported on Wednesday that 18 children, aged between five months and four years, died of acute kidney failure after being given the cough syrup
Indian authorities ordered a pharmaceutical factory to halt production today as part of an investigation into a cough syrup that the Uzbek government says is responsible for the deaths of at least 18 children.
“The results (of the investigation) are expected in a few days,” Dinesh Tiwari, a member of the drug control agency, told AFP. According to Tiwari, these syrups are not sold in India.
Health Minister Mansukh Madaviya tweeted that samples of the syrup had been taken and sent for analysis.
In Uzbekistan, media reported on Wednesday that 18 children, aged between five months and four years, died of acute kidney failure after being given the cough syrup Doc-1 Max. The country’s health ministry announced that the syrups were contaminated with ethylene glycol, a chemical, toxic substance used in the production of brake fluids, antifreeze, paints and some plastics as well as cosmetics.
Marion Biotech is the second Indian pharmaceutical company to come under investigation for health-threatening cough syrups. In the fall, the Gambian government reported that at least 66 children died after being given cold medicine and cough syrups made by Maiden Pharmaceuticals. The World Health Organization explained that these drugs contained an “unacceptably high” amount of ethylene glycol.
India investigated Maiden Pharmaceuticals but last week authorities assured that the quality of the “suspect” drugs was up to standard.
RES-EMP
Read the News today and get the latest news.
Follow Skai.gr on Google News and be the first to know all the news.
With a wealth of experience honed over 4+ years in journalism, I bring a seasoned voice to the world of news. Currently, I work as a freelance writer and editor, always seeking new opportunities to tell compelling stories in the field of world news.
